NCT05128071View on ClinicalTrials.gov

PRevention Of Methamphetamine Use Among Postpartum Women Trial (PROMPT)

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

February 4, 2022

Primary Completion Date

April 30, 2026

Study Completion Date

April 30, 2027

Conditions
Methamphetamine-dependencePostpartum Abstinence
Interventions
DRUG

Progesterone

Randomized to 400 mg (200 mg twice daily) oral micronized progesterone daily

DRUG

Placebo

Randomized to placebo twice daily

Trial Locations (1)

84132

RECRUITING

University of Utah, Salt Lake City

All Listed Sponsors
lead

University of Utah

OTHER